) have said they plan to make any successful vaccine available at cost, though they could reap profits later if a seasonal shot is needed. Multiple treatments could also divide the market between many players, investors said.
Signs of progress on potential treatments could bolster the case for a quicker economic recovery and further fuel the rally that has boosted the S&P 500 around 30% from its late March lows. In the next two weeks, Gilead Sciences is expected to announce results of clinical studies of its potential coronavirus treatment remdesivir for patients with moderate symptoms of Covid-19.
“If you’re looking for where the profits might be in the chain, it’s somebody like that who is going to benefit. They can cash in the whole way,” Cordisco said. He is staying away from potential vaccine producers in favor of companies such as Takeda Pharmaceutical Co Ltd . Japan’s largest pharmaceutical company said this month it could start clinical trials as early as July for a COVID-19 treatment based on antibodies from blood of recovered patients.
I'm sick and tired of hearing about the stock market. It is has no effect on working people's lives anymore. It's a casino/lottery system set up for rich people to fuck around with using other people's money.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: wwd - 🏆 24. / 68 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »